» Articles » PMID: 25516435

Anti-inflammatory Immune Skewing is Atheroprotective: Apoe−/−FcγRIIb−/− Mice Develop Fibrous Carotid Plaques

Overview
Date 2014 Dec 18
PMID 25516435
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Stroke, caused by carotid plaque rupture, is a major cause of death in the United States. Whereas vulnerable human plaques have higher Fc receptor (FcγR) expression than their stable counterparts, how FcγR expression impacts plaque histology is unknown. We investigated the role of FcγRIIb in carotid plaque development and stability in apolipoprotein (Apo)e−/− and Apoe−/−FcγRIIb−/− double knockout (DKO) animals.

Methods And Results: Plaques were induced by implantation of a shear stress‐modifying cast around the carotid artery. Plaque length and stenosis were followed longitudinally using ultrasound biomicroscopy. Immune status was determined by flow cytometry, cytokine release, immunoglobulin G concentration and analysis of macrophage polarization both in plaques and in vitro. Surprisingly, DKO animals had lower plaque burden in both carotid artery and descending aorta. Plaques from Apoe−/− mice were foam‐cell rich and resembled vulnerable human specimens, whereas those from DKO mice were fibrous and histologically stable. Plaques from DKO animals expressed higher arginase 1 (Arg‐1) and lower inducible nitric oxide synthase (iNOS), indicating the presence of M2 macrophages. Analysis of blood and cervical lymph nodes revealed higher interleukin (IL)‐10, immune complexes, and regulatory T cells (Tregs) and lower IL‐12, IL‐1β, and tumor necrosis factor alpha (TNF‐α) in DKO mice. Similarly, in vitro stimulation produced higher IL‐10 and Arg‐1 and lower iNOS, IL‐1β, and TNF‐α in DKO versus Apoe−/− macrophages. These results define a systemic anti‐inflammatory phenotype.

Conclusions: We hypothesized that removal of FcγRIIb would exacerbate atherosclerosis and generate unstable plaques. However, we found that deletion of FcγRIIb on a congenic C57BL/6 background induces an anti‐inflammatory Treg/M2 polarization that is atheroprotective.

Citing Articles

Myeloid Cell Diversity and Impact of Metabolic Cues during Atherosclerosis.

Gallerand A, Stunault M, Merlin J, Guinamard R, Yvan-Charvet L, Ivanov S Immunometabolism. 2024; 2(4):immunometab20200028.

PMID: 39649554 PMC: 7617020. DOI: 10.20900/immunometab20200028.


Macrophage Paired Immunoglobulin-Like Receptor B Deficiency Promotes Peripheral Atherosclerosis in Apolipoprotein E-Deficient Mice.

Su W, Liang L, Zhou L, Cao Y, Zhou X, Liu S Front Cell Dev Biol. 2022; 9:783954.

PMID: 35321392 PMC: 8936951. DOI: 10.3389/fcell.2021.783954.


B Cell Fcγ Receptor IIb Modulates Atherosclerosis in Male and Female Mice by Controlling Adaptive Germinal Center and Innate B-1-Cell Responses.

Bagchi-Chakraborty J, Francis A, Bray T, Masters L, Tsiantoulas D, Nus M Arterioscler Thromb Vasc Biol. 2019; 39(7):1379-1389.

PMID: 31092015 PMC: 6636804. DOI: 10.1161/ATVBAHA.118.312272.


FcγRIIb on CD11c cells modulates serum cholesterol and triglyceride levels and differentially affects atherosclerosis in male and female Ldlr mice.

Marvin J, Rhoads J, Major A Atherosclerosis. 2019; 285:108-119.

PMID: 31051414 PMC: 8086422. DOI: 10.1016/j.atherosclerosis.2019.04.221.


M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment.

Bi Y, Chen J, Hu F, Liu J, Li M, Zhao L Neural Plast. 2019; 2019:6724903.

PMID: 30923552 PMC: 6409015. DOI: 10.1155/2019/6724903.


References
1.
Larsen E, Ueyama T, Brannock P, Shirai Y, Saito N, Larsson C . A role for PKC-epsilon in Fc gammaR-mediated phagocytosis by RAW 264.7 cells. J Cell Biol. 2002; 159(6):939-44. PMC: 2173999. DOI: 10.1083/jcb.200205140. View

2.
Caligiuri G, Rudling M, Ollivier V, Jacob M, Michel J, Hansson G . Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med. 2003; 9(1-2):10-7. PMC: 1430379. View

3.
Lee J, Ye J, Gao Z, Youn H, Lee W, Zhao L . Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem. 2003; 278(39):37041-51. DOI: 10.1074/jbc.M305213200. View

4.
Potteaux S, Esposito B, van Oostrom O, Brun V, Ardouin P, Groux H . Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol. 2004; 24(8):1474-8. DOI: 10.1161/01.ATV.0000134378.86443.cd. View

5.
STARY H, Chandler A, Dinsmore R, Fuster V, Glagov S, INSULL Jr W . A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 1995; 15(9):1512-31. DOI: 10.1161/01.atv.15.9.1512. View